ATE67410T1 - Methode zur behandlung der antidiurese. - Google Patents

Methode zur behandlung der antidiurese.

Info

Publication number
ATE67410T1
ATE67410T1 AT85307088T AT85307088T ATE67410T1 AT E67410 T1 ATE67410 T1 AT E67410T1 AT 85307088 T AT85307088 T AT 85307088T AT 85307088 T AT85307088 T AT 85307088T AT E67410 T1 ATE67410 T1 AT E67410T1
Authority
AT
Austria
Prior art keywords
effective
antidiuresis
treatment
patients
anasarca
Prior art date
Application number
AT85307088T
Other languages
English (en)
Inventor
Junki Katsube
Mitsutaka Nakamura
Yukio Maeda
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Application granted granted Critical
Publication of ATE67410T1 publication Critical patent/ATE67410T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85307088T 1984-10-04 1985-10-03 Methode zur behandlung der antidiurese. ATE67410T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59208586A JPS6185318A (ja) 1984-10-04 1984-10-04 利尿薬
EP85307088A EP0177356B1 (de) 1984-10-04 1985-10-03 Methode zur Behandlung der Antidiurese

Publications (1)

Publication Number Publication Date
ATE67410T1 true ATE67410T1 (de) 1991-10-15

Family

ID=16558638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85307088T ATE67410T1 (de) 1984-10-04 1985-10-03 Methode zur behandlung der antidiurese.

Country Status (7)

Country Link
US (1) US4647587A (de)
EP (1) EP0177356B1 (de)
JP (1) JPS6185318A (de)
AT (1) ATE67410T1 (de)
AU (1) AU574978B2 (de)
CA (1) CA1267607A (de)
DE (1) DE3584131D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2603566B2 (ja) * 1991-03-27 1997-04-23 住友製薬株式会社 尿失禁治療剤
JP3559572B2 (ja) * 1993-01-29 2004-09-02 住友製薬株式会社 急性痛および慢性痛用鎮痛剤
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
WO2005025561A1 (en) * 2003-09-04 2005-03-24 Synergia Pharma, Inc. Compositions and methods for orthostatic intolerance
HRP20120479T1 (hr) * 2006-06-28 2012-07-31 Chelsea@Therapeutics@Inc Farmaceutski sastavi sa droksidopom
NZ579368A (en) * 2007-03-09 2012-03-30 Chelsea Therapeutics Inc Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
EP2514417A3 (de) * 2007-05-07 2013-01-30 Chelsea Therapeutics, Inc. Droxidopa und pharmazeutische Zusammensetzung davon, zur Behandlung von Stimmungsstörungen, Schlafstörungen oder Aufmerksamkeitsdefizit-Störungen
JP5880913B2 (ja) 2011-05-17 2016-03-09 三郎 佐古田 パーキンソン病の体幹症状(姿勢反射異常)の治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920728A (en) * 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
JPS52125630A (en) * 1976-04-14 1977-10-21 Kyowa Hakko Kogyo Co Ltd Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS56104815A (en) * 1980-01-23 1981-08-20 Sumitomo Chem Co Ltd Remedy for peripheral orthostatic hypotension
JPS5852219A (ja) * 1981-09-22 1983-03-28 Sumitomo Chem Co Ltd パ−キンソン病治療剤
JPS6067420A (ja) * 1983-09-22 1985-04-17 Sumitomo Chem Co Ltd 精神運動興奮抑制剤
AU575849B2 (en) * 1983-09-22 1988-08-11 Sumitomo Chemical Company, Limited Pharmaceutical composition and method for treatment of psychomotor excitement

Also Published As

Publication number Publication date
AU574978B2 (en) 1988-07-14
AU4827085A (en) 1986-04-24
JPS6185318A (ja) 1986-04-30
DE3584131D1 (de) 1991-10-24
EP0177356B1 (de) 1991-09-18
JPH0477728B2 (de) 1992-12-09
CA1267607A (en) 1990-04-10
EP0177356A3 (en) 1987-11-25
EP0177356A2 (de) 1986-04-09
US4647587A (en) 1987-03-03

Similar Documents

Publication Publication Date Title
DE3689974D1 (de) Arzneimittel zur Behandlung von Emesis.
DE3669103D1 (de) Ibuprofen enthaltendes arzneimittel.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE3581514D1 (de) Film zur behandlung von halbleiterwaffeln.
DE3777805D1 (de) Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
DE3218761A1 (de) Nonapeptid zur behandlung von suchtmittelentzugserscheinungen
TR24553A (tr) Granueler halinde fosfor icermiyen agartma-maddesi ni aktiflestirici bilesimleri
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
ATE67410T1 (de) Methode zur behandlung der antidiurese.
ATE50143T1 (de) Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
DE3670956D1 (de) Behandlung von fluessigkeiten.
NO155225C (no) Tannbehandlingspreparat inneholdende fluoridioner.
DE3485580D1 (de) Algorithmus zur verabreichung von insulin.
FR2584073B1 (fr) Analogues d'amino-prostaglandines a substituant 5,6-epoxy-7-oxabicycloheptane, utilisables pour le traitement des thromboses
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE3687865D1 (de) Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie.
ES283591Y (es) Una tableta de dosificacion farmaceutica adecuada para administracion oral
DE3483944D1 (de) Verwendung von selektiv peripheren dopamin-antagonisten zur herstellung eines arzneimittels zur topischen behandlung von okularer hypertension.
ATA188385A (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
DK160821C (da) 1,3-dihydro-4-benzoyl-2h-imidazol-2-oner samt middel til behandling af hjertesvigt
ATE146963T1 (de) Verwendung von tergurid zur herstellung eines arzneimittels zur behandlung geriatrischer beschwerden
NO870739L (no) Renset human angiogen faktor og fremgangsmŸte for dens fremstilling.
BG44874A3 (bg) Метод за получаване на кондензирани аs-триазини
ATE58476T1 (de) Verwendung von doxaminol zur herstellung eines arzneimittels zur behandlung der peripheren arteriellen verschlusskrankheit.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee